Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes
1 other identifier
interventional
16,146
1 country
1
Brief Summary
Each year, 10.4 million patients are diagnosed with and 1.7 million people die from Tuberculosis (TB). Despite the availability of highly effective and accessible medications in the developing world where TB is endemic, the 6-18 month treatment regimen is often thwarted as patients fail to comply due to a lack of knowledge about the disease, desire for privacy, and/or stigma avoidance. Successful TB treatment is critical for reducing transmission, the selection of drug-resistant strains and treatment costs. Mobile health interventions promise to increase treatment success, especially in regions where directly observed treatment (DOT) is impractical. The most promising interventions attempted thus far employ a combination of SMS reminders and medication monitors. However, there is relatively little high-quality evidence on their impact, and what evidence there is shows mixed success. In Kenya, the burden of TB is among the highest in the world with a prevalence rate of 558 cases per 100,000 people. There is a great need for the development of alternative protocols, which reduce the costs of treatment and burden of adherence, and more effectively motivate patients to adhere to the program. A substantial and growing literature in the social sciences demonstrates the potential of behavioral interventions for generating large increases in contributions to public goods. Keheala, a feature-phone and Internet-based digital platform that uses Unstructured Supplementary Service Data (USSD) technology to register a patient's self-verification of medication adherence alongside support and motivation, based on proven techniques from the behavioral sciences, was shown in a 1,200-patient randomized controlled trial (RCT) to reduce the unsuccessful TB treatment outcomes in Kenya by two-thirds compared to the standard of care protocol. This 15,500 patient RCT will compare Keheala's scalability, cost-effectiveness and social impact to alternative interventions across diverse regions of Kenya.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2018
CompletedStudy Start
First participant enrolled
April 13, 2018
CompletedFirst Posted
Study publicly available on registry
October 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2021
CompletedJanuary 21, 2022
January 1, 2022
2.1 years
March 28, 2018
January 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Unsuccessful Health Outcomes
Composite metric of died, failed and loss to follow up outcomes.
From date of randomization until the date of a documented treatment outcome, assessed up to 24 months after study enrollment date.
Deaths
A TB patient who dies for any reason during the course of treatment.
From date of randomization until the date of a documented treatment outcome, assessed up to 24 months after study enrollment date.
Secondary Outcomes (1)
Adherence
Assessed daily from date of randomization until the date of a documented treatment outcome, up to 24 months after study enrollment date.
Other Outcomes (9)
Unsuccessful treatment outcomes amongst multi-drug resistant patients.
From date of randomization until the date of a documented treatment outcome, assessed up to 24 months after study enrollment date.
Deaths amongst multi-drug resistant patients.
From date of randomization until the date of a documented treatment outcome, assessed up to 24 months after study enrollment date.
Survey responses: 1. Have you missed any additional time from work, school, household duties, or other activities because of your TB illness?
Patients are surveyed one week after their randomization date and once more three months after a health outcome has been entered. Assessed up to 27 months after study enrollment date.
- +6 more other outcomes
Study Arms (4)
Control
ACTIVE COMPARATORThe standard-of-care protocol in Kenya includes diagnosis, the provision of medications - typically administered for a 1-2 week period at which point patients are expected to return to the clinical site - periodic on-the-ground follow-up by community health volunteers (CHVs)(at the discretion of local clinicians and CHVs) and nutritional support, as is sometimes provided.
SMS-Only
EXPERIMENTALPatients in the SMS reminder group will receive a single, medication reminder SMS once daily at their indicated treatment time. The reminder message will read "Please take the medication on time" consistent with messages used by Liu and colleagues (2015).
Social Behavior Change Communication (SBCC)
EXPERIMENTALPatients assigned to this intervention will have access to a mobile health platform that provides reminders, information and motivation - designed with behaviorally-informed strategies - but no follow up support from a human beyond what the standard of care allows. Further details of the intervention can be found in the study protocol section. The intervention will send automated motivational messages and regular prompts for patients to self-verify their adherence. Messages include reminders about the community benefits of adherence, and a measure of the patient's adherence performance relative to successful peers. Clinicians can view individual or aggregate patient histories to leverage limited resources.
Keheala
EXPERIMENTALAn automated system sends motivational messages and regular prompts for patients to self-verify their adherence. Messages include reminders about the community benefits of adherence, and a measure of the patient's adherence performance relative to successful peers. If a patient fails to correctly verify her compliance, the system automatically alerts the support-sponsor, who then intervenes with a supportive dialogue. Clinicians can view individual or aggregate patient histories to leverage limited resources. Further details of the intervention can be found in the study protocol section.
Interventions
Keheala is a mobile health company that delivers powerful behavior change interventions from the social sciences across basic feature phones or smartphones to address the nonmedical drivers of disease, which exist away from health facilities. The intervention includes automated reminders, remote self-verification of doses, accessible TB information and individualized follow-up.
Automated reminders, remote self-verification of doses and accessible TB information. All interactions are behaviorally-informed but do not include regular adherence support/follow-up from study team members as the Keheala intervention does.
The standard-of-care protocol in Kenya includes diagnosis, the provision of medications - typically administered for a 1-2 week period at which point patients are expected to return to the clinical site - periodic on-the-ground follow-up by community health volunteers (CHVs)(at the discretion of local clinicians and CHVs) and nutritional support, as is sometimes provided.
Eligibility Criteria
You may not qualify if:
- \- subjects who do not consent to participate.
- Note that subjects are randomized into intervention groups or the control group after providing consent.
- Subjects who are enrolled but are found, retrospectively to not meet the criteria (i.e. they had less than two months remaining when they were enrolled) will be monitored as part of a, fifth "non-eligible" group, and will not count towards the enrollment targets.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts Institute of Technologylead
- Kehealacollaborator
- United States Agency for International Development (USAID)collaborator
- Kenya National Tuberculosis, Leprosy and Lung Disease Programcollaborator
- McGill Universitycollaborator
Study Sites (1)
Kenya National TB Program
Nairobi, Kenya
Related Publications (36)
Ayres, I., Raseman, S., & Shih, A. (2013). Evidence from two large field experiments that peer comparison feedback can reduce residential energy usage. Journal of Law, Economics, and Organization, 29(5), 992-1022
BACKGROUNDAndreoni, J., Rao, J. M., & Trachtman, H. (2011). Avoiding the ask: a field experiment on altruism, empathy, and charitable giving (No. w17648). National Bureau of Economic Research.
BACKGROUNDErshad Sarabi R, Sadoughi F, Jamshidi Orak R, Bahaadinbeigy K. The Effectiveness of Mobile Phone Text Messaging in Improving Medication Adherence for Patients with Chronic Diseases: A Systematic Review. Iran Red Crescent Med J. 2016 Apr 30;18(5):e25183. doi: 10.5812/ircmj.25183. eCollection 2016 May.
PMID: 27437126BACKGROUNDFinitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One. 2014 Feb 5;9(2):e88166. doi: 10.1371/journal.pone.0088166. eCollection 2014.
PMID: 24505411BACKGROUNDGehlbach, H., Brinkworth, M. E., King, A., Hsu, L., McIntyre, J., & Rogers, T. T. (2015). Creating birds of similar feathers: Leveraging similarity to improve teacher-student relationships and academic achievement.
BACKGROUNDGollwitzer, P. M. (1999). Implementation intentions: strong effects of simple plans. American psychologist, 54(7), 493.
BACKGROUNDGuerra RL, Conde MB, Efron A, Loredo C, Bastos G, Chaisson RE, Golub JE. Point-of-care Arkansas method for measuring adherence to treatment with isoniazid. Respir Med. 2010 May;104(5):754-7. doi: 10.1016/j.rmed.2010.02.001. Epub 2010 Mar 3.
PMID: 20202806BACKGROUNDHaberer JE, Musiimenta A, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC, Bangsberg DR. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016 May 15;30(8):1295-300. doi: 10.1097/QAD.0000000000001021.
PMID: 26760452BACKGROUNDHaberer JE, Musinguzi N, Tsai AC, Boum Y 2nd, Bwana BM, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring. AIDS. 2017 Jan 2;31(1):169-171. doi: 10.1097/QAD.0000000000001310.
PMID: 27835622BACKGROUNDHall AK, Cole-Lewis H, Bernhardt JM. Mobile text messaging for health: a systematic review of reviews. Annu Rev Public Health. 2015 Mar 18;36:393-415. doi: 10.1146/annurev-publhealth-031914-122855.
PMID: 25785892BACKGROUNDHallsworth, M., List, J. A., Metcalfe, R. D., & Vlaev, I. (2015). The Making of Homo Honoratus: From Omission to Commission (No. w21210). National Bureau of Economic Research.
BACKGROUNDHewstone M, Rubin M, Willis H. Intergroup bias. Annu Rev Psychol. 2002;53:575-604. doi: 10.1146/annurev.psych.53.100901.135109.
PMID: 11752497BACKGROUNDKarlin B, Zinger JF, Ford R. The effects of feedback on energy conservation: A meta-analysis. Psychol Bull. 2015 Nov;141(6):1205-27. doi: 10.1037/a0039650. Epub 2015 Sep 21.
PMID: 26390265BACKGROUNDKraft-Todd, G., Yoeli, E., Bhanot, S., & Rand, D. (2015). Promoting cooperation in the field. Current Opinion in Behavioral Sciences, 3, 96-101.
BACKGROUNDLiu X, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng G, Bai L, Li J, Li X, Chen H, Liu M, Chen R, Chi J, Lu J, Huan S, Cheng S, Wang L, Jiang S, Chin DP, Fielding KL. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial. PLoS Med. 2015 Sep 15;12(9):e1001876. doi: 10.1371/journal.pmed.1001876. eCollection 2015 Sep.
PMID: 26372470BACKGROUNDMalhotra, N., Michelson, M. R., Rogers, T., & Valenzuela, A. A. (2011). Text messages as mobilization tools: The conditional effect of habitual voting and election salience. American Politics Research, 39(4), 664-681.
BACKGROUNDMcLaren ZM, Milliken AA, Meyer AJ, Sharp AR. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy. BMC Infect Dis. 2016 Oct 4;16(1):537. doi: 10.1186/s12879-016-1862-y.
PMID: 27716104BACKGROUNDMetcalfe JZ, O'Donnell MR, Bangsberg DR. Moving Beyond Directly Observed Therapy for Tuberculosis. PLoS Med. 2015 Sep 15;12(9):e1001877. doi: 10.1371/journal.pmed.1001877. eCollection 2015 Sep. No abstract available.
PMID: 26372602BACKGROUNDMohammed S, Glennerster R, Khan AJ. Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled Trial. PLoS One. 2016 Nov 1;11(11):e0162944. doi: 10.1371/journal.pone.0162944. eCollection 2016.
PMID: 27802283BACKGROUNDNglazi MD, Bekker LG, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infect Dis. 2013 Dec 2;13:566. doi: 10.1186/1471-2334-13-566.
PMID: 24295439BACKGROUNDNicolau I, Tian L, Menzies D, Ostiguy G, Pai M. Point-of-care urine tests for smoking status and isoniazid treatment monitoring in adult patients. PLoS One. 2012;7(9):e45913. doi: 10.1371/journal.pone.0045913. Epub 2012 Sep 28.
PMID: 23029310BACKGROUNDPrestwich A, Perugini M, Hurling R. Can the effects of implementation intentions on exercise be enhanced using text messages? Psychol Health. 2009 Jul;24(6):677-87. doi: 10.1080/08870440802040715.
PMID: 20205020BACKGROUNDRand, D. G., Yoeli, E., & Hoffman, M. (2014). Harnessing reciprocity to promote cooperation and the provisioning of public goods. Policy Insights from the Behavioral and Brain Sciences, 1(1), 263-269.
BACKGROUNDRege, M., & Telle, K. (2004). The impact of social approval and framing on cooperation in public good situations. Journal of public Economics, 88(7), 1625-1644.
BACKGROUNDRogers, T., Milkman, K., John, L., & Norton, M. I. (2013). Making the best-laid plans better: how plan making increases follow-through. Cambridge, MA: Work. Pap., Harvard Univ.
BACKGROUNDSpranca, M., Minsk, E., & Baron, J. (1991). Omission and commission in judgment and choice. Journal of experimental social psychology, 27(1), 76-105.
BACKGROUNDTiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One. 2011 Apr 4;6(4):e17601. doi: 10.1371/journal.pone.0017601.
PMID: 21483732BACKGROUNDTola HH, Tol A, Shojaeizadeh D, Garmaroudi G. Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review. Iran J Public Health. 2015 Jan;44(1):1-11.
PMID: 26060770BACKGROUNDTuberculosis. (2015, October 1). Retrieved December 12, 2014, from http://www.who.int/mediacentre/factsheets/fs104/en/
BACKGROUNDWald DS, Butt S, Bestwick JP. One-way versus two-way text messaging on improving medication adherence: meta-analysis of randomized trials. Am J Med. 2015 Oct;128(10):1139.e1-5. doi: 10.1016/j.amjmed.2015.05.035. Epub 2015 Jun 16.
PMID: 26087045BACKGROUNDWeidle PJ, Wamai N, Solberg P, Liechty C, Sendagala S, Were W, Mermin J, Buchacz K, Behumbiize P, Ransom RL, Bunnell R. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet. 2006 Nov 4;368(9547):1587-94. doi: 10.1016/S0140-6736(06)69118-6.
PMID: 17084759BACKGROUNDWorld Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017.
BACKGROUNDWHO. (2014). Global Tuberculosis Report 2014. World Health Organization.
BACKGROUNDWHO. (2015). Global Tuberculosis Report 2015. World Health Organization.
BACKGROUNDYoeli E, Hoffman M, Rand DG, Nowak MA. Powering up with indirect reciprocity in a large-scale field experiment. Proc Natl Acad Sci U S A. 2013 Jun 18;110 Suppl 2(Suppl 2):10424-9. doi: 10.1073/pnas.1301210110. Epub 2013 Jun 10.
PMID: 23754399BACKGROUNDYoeli, Erez., David G Rand and Syon Bhanot. Mobile Self-Verification and Support for Tuberculosis Treatment Success: A Randomized Control Trial. Yale University Working Paper. 2018
RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Clinic staff are not explicitly informed of an individual's assignment, but it is not possible to mask them. It is also not possible to mask the study team members.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2018
First Posted
October 8, 2019
Study Start
April 13, 2018
Primary Completion
May 31, 2020
Study Completion
July 30, 2021
Last Updated
January 21, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share